An antibiotic selection marker for schistosome transgenesis

Drug selection is widely used in transgene studies of microbial pathogens, mammalian cell and plant cell lines. Drug selection of transgenic schistosomes would be desirable to provide a means to enrich for populations of transgenic worms. We adapted murine leukaemia retrovirus vectors - widely used...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriel Rinaldi, Sutas Suttiprapa, José F. Tort, Anne E. Folley, Danielle E. Skinner, Paul J. Brindley
Other Authors: George Washington University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/14364
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.14364
record_format dspace
spelling th-mahidol.143642018-06-11T12:19:58Z An antibiotic selection marker for schistosome transgenesis Gabriel Rinaldi Sutas Suttiprapa José F. Tort Anne E. Folley Danielle E. Skinner Paul J. Brindley George Washington University Universidad de la Republica Facultad de Medicina Mahidol University Immunology and Microbiology Medicine Drug selection is widely used in transgene studies of microbial pathogens, mammalian cell and plant cell lines. Drug selection of transgenic schistosomes would be desirable to provide a means to enrich for populations of transgenic worms. We adapted murine leukaemia retrovirus vectors - widely used in human gene therapy research - to transduce schistosomes, leading to integration of transgenes into the genome of the blood fluke. A dose-response kill curve and lethal G418 (geneticin) concentrations were established: 125-1,000 μg/ml G418 were progressively more toxic for schistosomules of Schistosoma mansoni with toxicity increasing with antibiotic concentration and with duration of exposure. By day 6 of exposure to ≥500 μg/ml, significantly fewer worms survived compared with non-exposed controls and by day 8, significantly fewer worms survived than controls at ≥250 μg/ml G418. When schistosomules were transduced with murine leukaemia retrovirus encoding the neomycin resistance (neoR) transgene and cultured in media containing G418, the neoR transgene rescued transgenic schistosomules from the antibiotic; by day 4 in 1,000 μg/ml and by day 8 in 500 μg/ml G418, significantly more transgenic worms survived the toxic effects of the antibiotic. More copies of neoR were detected per nanogram of genomic DNA from populations of transgenic schistosomes cultured in G418 than from transgenic schistosomes cultured without G418. This trend was G418 dose-dependent, demonstrating enrichment of transgenic worms from among the schistosomules exposed to virions. Furthermore, higher expression of neoR was detected in transgenic schistosomes cultured in the presence of G418 than in transgenic worms cultured without antibiotic. The availability of antibiotic selection can be expected to enhance progress with functional genomics research on the helminth parasites responsible for major neglected tropical diseases. © 2011 Australian Society for Parasitology Inc. 2018-06-11T04:55:12Z 2018-06-11T04:55:12Z 2012-01-01 Article International Journal for Parasitology. Vol.42, No.1 (2012), 123-130 10.1016/j.ijpara.2011.11.005 18790135 00207519 2-s2.0-84855200901 https://repository.li.mahidol.ac.th/handle/123456789/14364 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84855200901&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Immunology and Microbiology
Medicine
spellingShingle Immunology and Microbiology
Medicine
Gabriel Rinaldi
Sutas Suttiprapa
José F. Tort
Anne E. Folley
Danielle E. Skinner
Paul J. Brindley
An antibiotic selection marker for schistosome transgenesis
description Drug selection is widely used in transgene studies of microbial pathogens, mammalian cell and plant cell lines. Drug selection of transgenic schistosomes would be desirable to provide a means to enrich for populations of transgenic worms. We adapted murine leukaemia retrovirus vectors - widely used in human gene therapy research - to transduce schistosomes, leading to integration of transgenes into the genome of the blood fluke. A dose-response kill curve and lethal G418 (geneticin) concentrations were established: 125-1,000 μg/ml G418 were progressively more toxic for schistosomules of Schistosoma mansoni with toxicity increasing with antibiotic concentration and with duration of exposure. By day 6 of exposure to ≥500 μg/ml, significantly fewer worms survived compared with non-exposed controls and by day 8, significantly fewer worms survived than controls at ≥250 μg/ml G418. When schistosomules were transduced with murine leukaemia retrovirus encoding the neomycin resistance (neoR) transgene and cultured in media containing G418, the neoR transgene rescued transgenic schistosomules from the antibiotic; by day 4 in 1,000 μg/ml and by day 8 in 500 μg/ml G418, significantly more transgenic worms survived the toxic effects of the antibiotic. More copies of neoR were detected per nanogram of genomic DNA from populations of transgenic schistosomes cultured in G418 than from transgenic schistosomes cultured without G418. This trend was G418 dose-dependent, demonstrating enrichment of transgenic worms from among the schistosomules exposed to virions. Furthermore, higher expression of neoR was detected in transgenic schistosomes cultured in the presence of G418 than in transgenic worms cultured without antibiotic. The availability of antibiotic selection can be expected to enhance progress with functional genomics research on the helminth parasites responsible for major neglected tropical diseases. © 2011 Australian Society for Parasitology Inc.
author2 George Washington University
author_facet George Washington University
Gabriel Rinaldi
Sutas Suttiprapa
José F. Tort
Anne E. Folley
Danielle E. Skinner
Paul J. Brindley
format Article
author Gabriel Rinaldi
Sutas Suttiprapa
José F. Tort
Anne E. Folley
Danielle E. Skinner
Paul J. Brindley
author_sort Gabriel Rinaldi
title An antibiotic selection marker for schistosome transgenesis
title_short An antibiotic selection marker for schistosome transgenesis
title_full An antibiotic selection marker for schistosome transgenesis
title_fullStr An antibiotic selection marker for schistosome transgenesis
title_full_unstemmed An antibiotic selection marker for schistosome transgenesis
title_sort antibiotic selection marker for schistosome transgenesis
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/14364
_version_ 1763489771539136512